Amarantus Bioscience Holdings Inc (AMBS)

[JLM27]

But it isn't. The company originally stated that the results would be released by the end of Q3, and this timeline was reiterated in several of the company's presentations. The tweet then extended the timeline until this past Monday. I disagree that it takes any significant amount of time to craft a PR once the company receives the results. The PR is simply a brief report of the study's conclusions with a link. It could be done in very short order.

Should I be more patient? Probably. But let's call this what it is, a delay. I don't know what it means, but we need to continuously reevaluate the information that we have to justify our decisions. I still think holding my long position is justified, but I have to admit that if we still have no news by this time next week, I may not feel the same way.